Article

The HinduThe Hindu on 2021-08-24 13:58

Gennova’s mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials

The study will be conducted in the country at approximately 10-15 sites in Phase 2 and 22-27 sites in Phase 3.

Related news